November 2018

News

November 19, 2018

Arena Inks $1.2 Billion Deal With United Therapeutics – Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) | Seeking Alpha

Arena Pharmaceuticals (ARNA) and United Therapeutics (UTHR) announced on Nov. 15 that the two companies…

Super User 0

Love0

News

November 19, 2018

Baltimore-based AsclepiX Therapeutics raises $5M – Technical.ly Baltimore

Johns Hopkins spinout AsclepiX Therapeutics raised $5 million in new funding that will assist in…

Super User 0

Love0

california-life-science-report-2018-image

News

November 19, 2018

2019 California Life Sciences Industry Report – California Life Sciences Association

California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, and PwC…

Super User 0

Love0

News

November 19, 2018

5 Telehealth Insights from CMS’ Seema Verma – HealthLeaders Media

Telehealth is changing the face of healthcare, and Medicare must adapt, said the CMS administrator.…

Super User 0

Love0

News

November 19, 2018

TEDx Amplifies UMB’s Cutting-Edge Innovations – University of Maryland, Baltimore

The audience seated in an intimate ballroom at the University of Maryland, Baltimore (UMB) on…

Super User 0

Love0

News

November 19, 2018

Opportunities in genomic testing and precision medicine – McKinsey

Advanced analysis of genomic data integrated with electronic medical records and other data sets, combined…

Super User 0

Love0

News

November 19, 2018

HISTORIC DAY: Virginia Tech Innovation Campus key to Virginia attracting Amazon HQ2 – Virginia Tech

Virginia emerged as a winner in the fierce, nationwide competition to house a headquarters for…

Super User 0

Love0

News

November 19, 2018

Rexahn Pharmaceuticals Announces Leadership Transition – Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to…

Super User 0

Love0

News

November 19, 2018

SERAXIS Inc. publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy

SERAXIS Inc., a rapidly growing regenerative medicine company today announced the publication of important trial…

Super User 0

Love0

News

November 19, 2018

CRISPR, MaxCyte expand partnership into immuno-oncology – Pharmaceutical Business review

Gene editing company CRISPR Therapeutics and cell-based medicines and life sciences firm MaxCyte have expanded…

Super User 0

Love0

Arena Inks $1.2 Billion Deal With United Therapeutics – Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) | Seeking Alpha

Baltimore-based AsclepiX Therapeutics raises $5M – Technical.ly Baltimore

2019 California Life Sciences Industry Report – California Life Sciences Association

5 Telehealth Insights from CMS’ Seema Verma – HealthLeaders Media

TEDx Amplifies UMB’s Cutting-Edge Innovations – University of Maryland, Baltimore

Opportunities in genomic testing and precision medicine – McKinsey

HISTORIC DAY: Virginia Tech Innovation Campus key to Virginia attracting Amazon HQ2 – Virginia Tech

Rexahn Pharmaceuticals Announces Leadership Transition – Rexahn Pharmaceuticals, Inc.

SERAXIS Inc. publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy

CRISPR, MaxCyte expand partnership into immuno-oncology – Pharmaceutical Business review

About BioHealth Innovation

Contact

Connect